Sbârcea, L.; Tănase, I.-M.; Ledeți, A.; Cîrcioban, D.; Vlase, G.; Barvinschi, P.; Miclău, M.; Văruţ, R.-M.; Suciu, O.; Ledeți, I.
Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients. Molecules 2021, 26, 1690.
https://doi.org/10.3390/molecules26061690
AMA Style
Sbârcea L, Tănase I-M, Ledeți A, Cîrcioban D, Vlase G, Barvinschi P, Miclău M, Văruţ R-M, Suciu O, Ledeți I.
Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients. Molecules. 2021; 26(6):1690.
https://doi.org/10.3390/molecules26061690
Chicago/Turabian Style
Sbârcea, Laura, Ionuț-Mihai Tănase, Adriana Ledeți, Denisa Cîrcioban, Gabriela Vlase, Paul Barvinschi, Marinela Miclău, Renata-Maria Văruţ, Oana Suciu, and Ionuț Ledeți.
2021. "Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients" Molecules 26, no. 6: 1690.
https://doi.org/10.3390/molecules26061690
APA Style
Sbârcea, L., Tănase, I. -M., Ledeți, A., Cîrcioban, D., Vlase, G., Barvinschi, P., Miclău, M., Văruţ, R. -M., Suciu, O., & Ledeți, I.
(2021). Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients. Molecules, 26(6), 1690.
https://doi.org/10.3390/molecules26061690